Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)
- First Posted Date
- 2011-05-30
- Last Posted Date
- 2016-03-10
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 127
- Registration Number
- NCT01362426
Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Phase 2
Completed
- Conditions
- HIV-1
- Interventions
- Genetic: OZ1 transduced cells
- First Posted Date
- 2010-08-06
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 68
- Registration Number
- NCT01177059
Schizophrenia Treatment Adherence Investigation (STAI)
Completed
- Conditions
- Schizoaffective DisorderSchizophrenia
- Interventions
- Other: Risk status for medication adherence
- First Posted Date
- 2009-10-26
- Last Posted Date
- 2014-04-09
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 550
- Registration Number
- NCT01001481
A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma
- Interventions
- Drug: PAD induction
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2014-05-16
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 107
- Registration Number
- NCT00872521
A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus
Phase 4
Completed
- Conditions
- Kidney TransplantionRenal Transplantion
- Interventions
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 55
- Registration Number
- NCT00492661
An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2012-12-05
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 64
- Registration Number
- NCT00473434
A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg
- First Posted Date
- 2007-04-23
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 1392
- Registration Number
- NCT00464308
An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period
- First Posted Date
- 2006-03-07
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 61
- Registration Number
- NCT00299676
Prospective Research in Memory Clinics (PRIME)
Completed
- Conditions
- DementiaMild Cognitive Impairment
- Interventions
- Other: Current treatment practice of each participating physician
- First Posted Date
- 2006-02-28
- Last Posted Date
- 2013-12-02
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 970
- Registration Number
- NCT00297271
Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
Phase 4
Completed
- Conditions
- Kidney TransplantationTransplantation
- First Posted Date
- 2006-02-28
- Last Posted Date
- 2011-06-20
- Lead Sponsor
- Janssen-Cilag Pty Ltd
- Target Recruit Count
- 89
- Registration Number
- NCT00297310
© Copyright 2025. All Rights Reserved by MedPath